[1] | Serth J, Panitz F, Paeslack U, Kuczyk MA, Jonas U. Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res. 1999 ; 59: 823–825. |
[2] | Ibrahim GK, Gravitt PE, Dittrich KL, Ibrahim SN, Melhus O, Anderson SM, Robertson CN. Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J. Urol. . 1992; 148: 1822–1826. |
[3] | Strickler HD, Burk R, Shah K. A multifaceted study of human papillomavirus and prostate carcinoma. Cancer.1998; 82: 1118–1125. |
[4] | Griffiths TR, and Mellon JK. Human papillomavirus and urological tumours: II. Role in bladder, prostate, renal and testicular cancer. BJU Int. 2000; 85: 211–217. |
[5] | Suzuki H , Komiya A, Aida S, Ito H, Yatani R , and Shimazaki J. Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer. Prostate. 1996 ; 28: 318–324. |
[6] | Hayes RB, Pottern LM, Strickler HD. Sexual behaviour, STDs and risks for prostate cancer. Br. J. Cancer. 2000; 82: 718–725. |
[7] | Munoz N, Bosch FX, de Sanjose S, Herrero R , Castellsague X, Shah KV, Snijders PJ, and Meijer CJ . Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 2003; 348: 518–527. |
[8] | Dillner J, Knekt P, Boman J, Lehtinen MAF , Geijersstam V, Sapp M, Schiller J, Maatela J, and Aromaa A. Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int. J. Cancer.1998; 75: 564–567. |
[9] | Hisada M , Rabkin CS, Strickler HD, Wright WE, Christianson RE, and van den Berg BJ. Human papillomavirus antibody and risk of prostate cancer. J. Am. Med. Assoc. 2000; 283: 340–341. |
[10] | Rosenblatt KA, Carter JJ, Iwasaki LM, Galloway DA, and Stanford JL. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 2003; 12: 763–768. |
[11] | Baker LH, Mebust WK, Chin TD, Chapman AL, Hinthorn D, and Towle D. The relationship of Herpes virus to carcinoma of the prostate. J. Urol. 1981; 125: 370–374. |
[12] | Herbert JT, Birkhoff JD, Feorino PM, and Caldwell GG. Herpes simplex virus type 2 and cancer of the prostate. J. Urol. 1976 ; 116: 611–612. |
[13] | Hoffman LJ, Bunker CH , Pellett PE, Trump DL, Patrick AL, Dollard SC, Keenan HA, and Jenkins F J. Elevated seroprevalence of human Herpes virus 8 among men with prostate cancer. J. Infect. Dis.2004; 189: 15–20. |
[14] | Sitas F, Carrara H , Beral V. Antibodies against human Herpes virus 8 in black South African patients with cancer. N. Engl. J. Med. 1999; 340 : 1863–1871. |
[15] | Deng H , Song MJ, Chu JT, and Sun R. Transcriptional regulation of the interleukin-6 gene of human Herpes virus 8 (Kaposi's sarcoma-associated Herpes virus). J. Virol. 2002; 76: 8252–8264. |
[16] | Samanta M, Harkins L , Klemm K, Britt WJ, and Cobbs CS. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. J. Urol. 2003; 170: 998–1002. |
[17] | National Center for Infectious Diseases. Cytomegalovirus (CMV) Infection, 2002. |
[18] | National Center for Infectious Diseases. Epstein-Barr Virus and Infectious Mononucleosis, 2003. |
[19] | Grinstein S, Preciado MV, Gattuso P, Chabay PA, Warren WH, De Matteo E. and Gould VE. (2002) Demonstration of Epstein-Barr virus in carcinomas of various sites. Cancer Res., . 2002 ; 62: 4876–4878. |
[20] | Haid M, and Sharon N. Immunofluorescent evidence of prior herpes simplex virus type-2 infection in prostate carcinoma. Urology, 1984; 24: 623–625. |
[21] | Eizuru Y, Hyman RW, Nahhas WA, and Rapp F. Herpes virus RNA in human urogenital tumors. Proc. Soc. Exp. Biol. Med. 1983; 174 : 296–301. |
[22] | Boldogh I , Baskar JF, Mar EC, and Huang ES. Human cytomegalovirus and herpes simplex type 2 virus in normal and Adenocarcinomatous prostate glands. J. Natl Cancer Inst.1983; 70: 819–826. |
[23] | Tu H, Jacobs SC , Mergner WJ, and Kyprianou N. Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. Urology.1994 ; 44:726–731. |